1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Generic Drugs 1.2.3 Clinical Trial Failed Drugs 1.3 Market by Application 1.3.1 Global Drug Repositioning Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular Diseases 1.3.3 Mental Illness 1.3.4 Cancer 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drug Repositioning Market Perspective (2016-2027) 2.2 Drug Repositioning Growth Trends by Regions 2.2.1 Drug Repositioning Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Drug Repositioning Historic Market Share by Regions (2016-2021) 2.2.3 Drug Repositioning Forecasted Market Size by Regions (2022-2027) 2.3 Drug Repositioning Industry Dynamic 2.3.1 Drug Repositioning Market Trends 2.3.2 Drug Repositioning Market Drivers 2.3.3 Drug Repositioning Market Challenges 2.3.4 Drug Repositioning Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Repositioning Players by Revenue 3.1.1 Global Top Drug Repositioning Players by Revenue (2016-2021) 3.1.2 Global Drug Repositioning Revenue Market Share by Players (2016-2021) 3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Drug Repositioning Revenue 3.4 Global Drug Repositioning Market Concentration Ratio 3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2020 3.5 Drug Repositioning Key Players Head office and Area Served 3.6 Key Players Drug Repositioning Product Solution and Service 3.7 Date of Enter into Drug Repositioning Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Repositioning Breakdown Data by Type 4.1 Global Drug Repositioning Historic Market Size by Type (2016-2021) 4.2 Global Drug Repositioning Forecasted Market Size by Type (2022-2027) 5 Drug Repositioning Breakdown Data by Application 5.1 Global Drug Repositioning Historic Market Size by Application (2016-2021) 5.2 Global Drug Repositioning Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Drug Repositioning Market Size (2016-2027) 6.2 North America Drug Repositioning Market Size by Type 6.2.1 North America Drug Repositioning Market Size by Type (2016-2021) 6.2.2 North America Drug Repositioning Market Size by Type (2022-2027) 6.2.3 North America Drug Repositioning Market Size by Type (2016-2027) 6.3 North America Drug Repositioning Market Size by Application 6.3.1 North America Drug Repositioning Market Size by Application (2016-2021) 6.3.2 North America Drug Repositioning Market Size by Application (2022-2027) 6.3.3 North America Drug Repositioning Market Size by Application (2016-2027) 6.4 North America Drug Repositioning Market Size by Country 6.4.1 North America Drug Repositioning Market Size by Country (2016-2021) 6.4.2 North America Drug Repositioning Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Drug Repositioning Market Size (2016-2027) 7.2 Europe Drug Repositioning Market Size by Type 7.2.1 Europe Drug Repositioning Market Size by Type (2016-2021) 7.2.2 Europe Drug Repositioning Market Size by Type (2022-2027) 7.2.3 Europe Drug Repositioning Market Size by Type (2016-2027) 7.3 Europe Drug Repositioning Market Size by Application 7.3.1 Europe Drug Repositioning Market Size by Application (2016-2021) 7.3.2 Europe Drug Repositioning Market Size by Application (2022-2027) 7.3.3 Europe Drug Repositioning Market Size by Application (2016-2027) 7.4 Europe Drug Repositioning Market Size by Country 7.4.1 Europe Drug Repositioning Market Size by Country (2016-2021) 7.4.2 Europe Drug Repositioning Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Drug Repositioning Market Size (2016-2027) 8.2 Asia-Pacific Drug Repositioning Market Size by Type 8.2.1 Asia-Pacific Drug Repositioning Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Drug Repositioning Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Drug Repositioning Market Size by Type (2016-2027) 8.3 Asia-Pacific Drug Repositioning Market Size by Application 8.3.1 Asia-Pacific Drug Repositioning Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Drug Repositioning Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Drug Repositioning Market Size by Application (2016-2027) 8.4 Asia-Pacific Drug Repositioning Market Size by Region 8.4.1 Asia-Pacific Drug Repositioning Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Drug Repositioning Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Drug Repositioning Market Size (2016-2027) 9.2 Latin America Drug Repositioning Market Size by Type 9.2.1 Latin America Drug Repositioning Market Size by Type (2016-2021) 9.2.2 Latin America Drug Repositioning Market Size by Type (2022-2027) 9.2.3 Latin America Drug Repositioning Market Size by Type (2016-2027) 9.3 Latin America Drug Repositioning Market Size by Application 9.3.1 Latin America Drug Repositioning Market Size by Application (2016-2021) 9.3.2 Latin America Drug Repositioning Market Size by Application (2022-2027) 9.3.3 Latin America Drug Repositioning Market Size by Application (2016-2027) 9.4 Latin America Drug Repositioning Market Size by Country 9.4.1 Latin America Drug Repositioning Market Size by Country (2016-2021) 9.4.2 Latin America Drug Repositioning Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Repositioning Market Size (2016-2027) 10.2 Middle East & Africa Drug Repositioning Market Size by Type 10.2.1 Middle East & Africa Drug Repositioning Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Drug Repositioning Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Drug Repositioning Market Size by Type (2016-2027) 10.3 Middle East & Africa Drug Repositioning Market Size by Application 10.3.1 Middle East & Africa Drug Repositioning Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Drug Repositioning Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Drug Repositioning Market Size by Application (2016-2027) 10.4 Middle East & Africa Drug Repositioning Market Size by Country 10.4.1 Middle East & Africa Drug Repositioning Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Drug Repositioning Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Teva 11.1.1 Teva Company Details 11.1.2 Teva Business Overview 11.1.3 Teva Drug Repositioning Introduction 11.1.4 Teva Revenue in Drug Repositioning Business (2016-2021) 11.1.5 Teva Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Drug Repositioning Introduction 11.2.4 Novartis Revenue in Drug Repositioning Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Mylan 11.3.1 Mylan Company Details 11.3.2 Mylan Business Overview 11.3.3 Mylan Drug Repositioning Introduction 11.3.4 Mylan Revenue in Drug Repositioning Business (2016-2021) 11.3.5 Mylan Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Drug Repositioning Introduction 11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2016-2021) 11.4.5 Johnson & Johnson Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Drug Repositioning Introduction 11.5.4 Pfizer Revenue in Drug Repositioning Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Bausch Health 11.6.1 Bausch Health Company Details 11.6.2 Bausch Health Business Overview 11.6.3 Bausch Health Drug Repositioning Introduction 11.6.4 Bausch Health Revenue in Drug Repositioning Business (2016-2021) 11.6.5 Bausch Health Recent Development 11.7 GSK 11.7.1 GSK Company Details 11.7.2 GSK Business Overview 11.7.3 GSK Drug Repositioning Introduction 11.7.4 GSK Revenue in Drug Repositioning Business (2016-2021) 11.7.5 GSK Recent Development 11.8 ChemRar Group 11.8.1 ChemRar Group Company Details 11.8.2 ChemRar Group Business Overview 11.8.3 ChemRar Group Drug Repositioning Introduction 11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2016-2021) 11.8.5 ChemRar Group Recent Development 11.9 Glenmark 11.9.1 Glenmark Company Details 11.9.2 Glenmark Business Overview 11.9.3 Glenmark Drug Repositioning Introduction 11.9.4 Glenmark Revenue in Drug Repositioning Business (2016-2021) 11.9.5 Glenmark Recent Development 11.10 Fujifilm 11.10.1 Fujifilm Company Details 11.10.2 Fujifilm Business Overview 11.10.3 Fujifilm Drug Repositioning Introduction 11.10.4 Fujifilm Revenue in Drug Repositioning Business (2016-2021) 11.10.5 Fujifilm Recent Development 11.11 Dr. Reddy 11.11.1 Dr. Reddy Company Details 11.11.2 Dr. Reddy Business Overview 11.11.3 Dr. Reddy Drug Repositioning Introduction 11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2016-2021) 11.11.5 Dr. Reddy Recent Development 11.12 R-Pharma 11.12.1 R-Pharma Company Details 11.12.2 R-Pharma Business Overview 11.12.3 R-Pharma Drug Repositioning Introduction 11.12.4 R-Pharma Revenue in Drug Repositioning Business (2016-2021) 11.12.5 R-Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Generic Drugs 1.2.3 Clinical Trial Failed Drugs 1.3 Market by Application 1.3.1 Global Drug Repositioning Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular Diseases 1.3.3 Mental Illness 1.3.4 Cancer 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drug Repositioning Market Perspective (2016-2027) 2.2 Drug Repositioning Growth Trends by Regions 2.2.1 Drug Repositioning Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Drug Repositioning Historic Market Share by Regions (2016-2021) 2.2.3 Drug Repositioning Forecasted Market Size by Regions (2022-2027) 2.3 Drug Repositioning Industry Dynamic 2.3.1 Drug Repositioning Market Trends 2.3.2 Drug Repositioning Market Drivers 2.3.3 Drug Repositioning Market Challenges 2.3.4 Drug Repositioning Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Repositioning Players by Revenue 3.1.1 Global Top Drug Repositioning Players by Revenue (2016-2021) 3.1.2 Global Drug Repositioning Revenue Market Share by Players (2016-2021) 3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Drug Repositioning Revenue 3.4 Global Drug Repositioning Market Concentration Ratio 3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2020 3.5 Drug Repositioning Key Players Head office and Area Served 3.6 Key Players Drug Repositioning Product Solution and Service 3.7 Date of Enter into Drug Repositioning Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Repositioning Breakdown Data by Type 4.1 Global Drug Repositioning Historic Market Size by Type (2016-2021) 4.2 Global Drug Repositioning Forecasted Market Size by Type (2022-2027) 5 Drug Repositioning Breakdown Data by Application 5.1 Global Drug Repositioning Historic Market Size by Application (2016-2021) 5.2 Global Drug Repositioning Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Drug Repositioning Market Size (2016-2027) 6.2 North America Drug Repositioning Market Size by Type 6.2.1 North America Drug Repositioning Market Size by Type (2016-2021) 6.2.2 North America Drug Repositioning Market Size by Type (2022-2027) 6.2.3 North America Drug Repositioning Market Size by Type (2016-2027) 6.3 North America Drug Repositioning Market Size by Application 6.3.1 North America Drug Repositioning Market Size by Application (2016-2021) 6.3.2 North America Drug Repositioning Market Size by Application (2022-2027) 6.3.3 North America Drug Repositioning Market Size by Application (2016-2027) 6.4 North America Drug Repositioning Market Size by Country 6.4.1 North America Drug Repositioning Market Size by Country (2016-2021) 6.4.2 North America Drug Repositioning Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Drug Repositioning Market Size (2016-2027) 7.2 Europe Drug Repositioning Market Size by Type 7.2.1 Europe Drug Repositioning Market Size by Type (2016-2021) 7.2.2 Europe Drug Repositioning Market Size by Type (2022-2027) 7.2.3 Europe Drug Repositioning Market Size by Type (2016-2027) 7.3 Europe Drug Repositioning Market Size by Application 7.3.1 Europe Drug Repositioning Market Size by Application (2016-2021) 7.3.2 Europe Drug Repositioning Market Size by Application (2022-2027) 7.3.3 Europe Drug Repositioning Market Size by Application (2016-2027) 7.4 Europe Drug Repositioning Market Size by Country 7.4.1 Europe Drug Repositioning Market Size by Country (2016-2021) 7.4.2 Europe Drug Repositioning Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Drug Repositioning Market Size (2016-2027) 8.2 Asia-Pacific Drug Repositioning Market Size by Type 8.2.1 Asia-Pacific Drug Repositioning Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Drug Repositioning Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Drug Repositioning Market Size by Type (2016-2027) 8.3 Asia-Pacific Drug Repositioning Market Size by Application 8.3.1 Asia-Pacific Drug Repositioning Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Drug Repositioning Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Drug Repositioning Market Size by Application (2016-2027) 8.4 Asia-Pacific Drug Repositioning Market Size by Region 8.4.1 Asia-Pacific Drug Repositioning Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Drug Repositioning Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Drug Repositioning Market Size (2016-2027) 9.2 Latin America Drug Repositioning Market Size by Type 9.2.1 Latin America Drug Repositioning Market Size by Type (2016-2021) 9.2.2 Latin America Drug Repositioning Market Size by Type (2022-2027) 9.2.3 Latin America Drug Repositioning Market Size by Type (2016-2027) 9.3 Latin America Drug Repositioning Market Size by Application 9.3.1 Latin America Drug Repositioning Market Size by Application (2016-2021) 9.3.2 Latin America Drug Repositioning Market Size by Application (2022-2027) 9.3.3 Latin America Drug Repositioning Market Size by Application (2016-2027) 9.4 Latin America Drug Repositioning Market Size by Country 9.4.1 Latin America Drug Repositioning Market Size by Country (2016-2021) 9.4.2 Latin America Drug Repositioning Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Repositioning Market Size (2016-2027) 10.2 Middle East & Africa Drug Repositioning Market Size by Type 10.2.1 Middle East & Africa Drug Repositioning Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Drug Repositioning Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Drug Repositioning Market Size by Type (2016-2027) 10.3 Middle East & Africa Drug Repositioning Market Size by Application 10.3.1 Middle East & Africa Drug Repositioning Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Drug Repositioning Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Drug Repositioning Market Size by Application (2016-2027) 10.4 Middle East & Africa Drug Repositioning Market Size by Country 10.4.1 Middle East & Africa Drug Repositioning Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Drug Repositioning Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Teva 11.1.1 Teva Company Details 11.1.2 Teva Business Overview 11.1.3 Teva Drug Repositioning Introduction 11.1.4 Teva Revenue in Drug Repositioning Business (2016-2021) 11.1.5 Teva Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Drug Repositioning Introduction 11.2.4 Novartis Revenue in Drug Repositioning Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Mylan 11.3.1 Mylan Company Details 11.3.2 Mylan Business Overview 11.3.3 Mylan Drug Repositioning Introduction 11.3.4 Mylan Revenue in Drug Repositioning Business (2016-2021) 11.3.5 Mylan Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Drug Repositioning Introduction 11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2016-2021) 11.4.5 Johnson & Johnson Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Drug Repositioning Introduction 11.5.4 Pfizer Revenue in Drug Repositioning Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Bausch Health 11.6.1 Bausch Health Company Details 11.6.2 Bausch Health Business Overview 11.6.3 Bausch Health Drug Repositioning Introduction 11.6.4 Bausch Health Revenue in Drug Repositioning Business (2016-2021) 11.6.5 Bausch Health Recent Development 11.7 GSK 11.7.1 GSK Company Details 11.7.2 GSK Business Overview 11.7.3 GSK Drug Repositioning Introduction 11.7.4 GSK Revenue in Drug Repositioning Business (2016-2021) 11.7.5 GSK Recent Development 11.8 ChemRar Group 11.8.1 ChemRar Group Company Details 11.8.2 ChemRar Group Business Overview 11.8.3 ChemRar Group Drug Repositioning Introduction 11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2016-2021) 11.8.5 ChemRar Group Recent Development 11.9 Glenmark 11.9.1 Glenmark Company Details 11.9.2 Glenmark Business Overview 11.9.3 Glenmark Drug Repositioning Introduction 11.9.4 Glenmark Revenue in Drug Repositioning Business (2016-2021) 11.9.5 Glenmark Recent Development 11.10 Fujifilm 11.10.1 Fujifilm Company Details 11.10.2 Fujifilm Business Overview 11.10.3 Fujifilm Drug Repositioning Introduction 11.10.4 Fujifilm Revenue in Drug Repositioning Business (2016-2021) 11.10.5 Fujifilm Recent Development 11.11 Dr. Reddy 11.11.1 Dr. Reddy Company Details 11.11.2 Dr. Reddy Business Overview 11.11.3 Dr. Reddy Drug Repositioning Introduction 11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2016-2021) 11.11.5 Dr. Reddy Recent Development 11.12 R-Pharma 11.12.1 R-Pharma Company Details 11.12.2 R-Pharma Business Overview 11.12.3 R-Pharma Drug Repositioning Introduction 11.12.4 R-Pharma Revenue in Drug Repositioning Business (2016-2021) 11.12.5 R-Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

Teva Novartis Mylan Johnson & Johnson Pfizer Bausch Health GSK ChemRar Group Glenmark Fujifilm Dr. Reddy R-Pharma